GlassScriptPhysician profile
Fred Earhart Aubert
NPI 1952307878
$9,461.30
in general payments reported to CMS, 2019-2025
52 companies · $1,649 in 2025
The $1,649 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,118 · 2020: $91.90 · 2021: $474 · 2022: $1,727 · 2023: $2,137 · 2024: $2,264 · 2025: $1,649.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,050.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,049.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $894.62 | 2019-2024 | |
| Abbvie INC. | $794.76 | 2021-2025 | Qulipta, Ubrelvy, Botox |
| Ucb, INC. | $617.55 | 2021-2025 | Briviact, Nayzilam, Zilbrysq |
| Lundbeck LLC | $582.93 | 2022-2025 | Vyepti, Rexulti |
| Novartis Pharmaceuticals Corporation | $499.50 | 2021-2025 | |
| Pfizer INC. | $486.66 | 2023-2025 | |
| Amgen INC. | $364.83 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $363.42 | 2022-2025 | Ultomiris |
| Biogen, INC. | $351.88 | 2021-2025 | Vumerity, Skyclarys, Leqembi |
| Sk Life Science, INC. | $329.41 | 2021-2025 | |
| Argenx US, INC. | $310.10 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Celgene Corporation | $288.47 | 2021-2025 | Zeposia |
| Lilly USA, LLC | $271.39 | 2021-2025 | Emgality, Amyvid, Reyvow |
| Acadia Pharmaceuticals INC | $245.87 | 2021-2025 | Nuplazid |
| Eisai INC. | $240.26 | 2023-2025 |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fred Aubert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.